ELEVAI LABS INC (ELAB)

US28622K1043 - Common Stock

0.0203  0 (-5.14%)

Fundamental Rating

2

Taking everything into account, ELAB scores 2 out of 10 in our fundamental rating. ELAB was compared to 36 industry peers in the Personal Care Products industry. While ELAB seems to be doing ok healthwise, there are quite some concerns on its profitability. ELAB is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

ELAB had negative earnings in the past year.
ELAB had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -93.51%, ELAB is not doing good in the industry: 91.43% of the companies in the same industry are doing better.
The Return On Equity of ELAB (-179.98%) is worse than 82.86% of its industry peers.
Industry RankSector Rank
ROA -93.51%
ROE -179.98%
ROIC N/A
ROA(3y)-98.18%
ROA(5y)N/A
ROE(3y)-148.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 69.25%, ELAB is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for ELAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

ELAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
ELAB has about the same amout of shares outstanding than it did 1 year ago.
ELAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -5.30, we must say that ELAB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ELAB (-5.30) is worse than 91.43% of its industry peers.
ELAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.3
ROIC/WACCN/A
WACC9.03%

2.3 Liquidity

A Current Ratio of 1.05 indicates that ELAB should not have too much problems paying its short term obligations.
ELAB's Current ratio of 1.05 is on the low side compared to the rest of the industry. ELAB is outperformed by 74.29% of its industry peers.
A Quick Ratio of 0.54 indicates that ELAB may have some problems paying its short term obligations.
ELAB's Quick ratio of 0.54 is on the low side compared to the rest of the industry. ELAB is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.54

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ELAB have decreased strongly by -148.22% in the last year.
Looking at the last year, ELAB shows a very strong growth in Revenue. The Revenue has grown by 122.42%.
EPS 1Y (TTM)-148.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.27%
Revenue 1Y (TTM)122.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%89.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ELAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ELAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELEVAI LABS INC

NASDAQ:ELAB (11/21/2024, 10:16:07 AM)

0.0203

0 (-5.14%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap448.63K
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -93.51%
ROE -179.98%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 69.25%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.05
Quick Ratio 0.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-148.22%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)122.42%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y